Next, depending on the HBV-positive HCC in the TCGA cohort, we further evaluated the correlation of identified TRIM genes with multiple clinical factors, including Age, fibrosis, gender, AFP levels, neoplasm histologic grade, and vascular invasion. This evidence concerns the gene TRAT1 and hepatocellular carcinoma.